Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,179.27
+9.67 (+0.83%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?
↗
Today 19:29 EDT
IBB has delivered stronger returns than IYH but with dramatically sharper swings in both directions. Here is how to decide which trade-off fits your portfolio.
Via
The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?
↗
Today 18:06 EDT
One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.
Via
The Motley Fool
Topics
ETFs
Prediction: My Top 2 Stocks to Buy Now Will Outperform the Stock Market Over the Next Decade
↗
Today 10:55 EDT
These elite businesses could help you build lasting wealth.
Via
The Motley Fool
Topics
Artificial Intelligence
As GLP-1 Drugs Change How People Eat, Drugmakers Collect and Snack Makers Feel the Squeeze
↗
Today 5:35 EDT
The weight-loss drugs are growing in popularity and altering consumer behavior in significant ways.
Via
The Motley Fool
Better Pharma ETF: iShares IHE vs. State Street XPH
↗
October 10, 2026
IHE concentrates 23.6% in Eli Lilly and delivers 1.4% yield, while XPH spreads risk across 62 holdings with a lower 0.35% expense ratio.
Via
The Motley Fool
Topics
ETFs
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?
↗
October 10, 2026
Viking's weight loss pill program has a couple of issues, including the fierce competitors who have a big head start.
Via
The Motley Fool
1 Healthcare Stock Worth Your Attention and 2 We Turn Down
October 09, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...
Via
StockStory
UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.
↗
October 08, 2026
UBS analyst Michael Yee called Novo Nordisk a value trap, but still sees a turnaround playing out over time.
Via
The Motley Fool
2 Growth Stocks to Buy in October
↗
October 08, 2026
Grail and Veeva Systems could be well insulated from near-term headwinds.
Via
The Motley Fool
Stay informed with the top movers within the S&P500 index on Thursday.
↗
October 08, 2026
Via
Chartmill
Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform
↗
October 08, 2026
Eli Lilly's obesity lead is only the starting point. See what its pipeline, manufacturing build-out, pricing pressure, and earnings trajectory could mean for the stock's next chapter.
Via
The Motley Fool
Which S&P500 stocks are gapping on Thursday?
↗
October 08, 2026
Via
Chartmill
Only 20 Stocks Are Holding Up the Market: 3 Bargains Outside AI
↗
October 08, 2026
Stansberry Research's Whitney Tilson argues record highs mask a bifurcated market, favoring Joby Aviation, Casey's General Stores, and Eli Lilly as value picks outside the AI trade.
Via
MarketBeat
Topics
Artificial Intelligence
Pfizer Trades Under 10 Times Forward Earnings With a Yield Near 6%. Here's What History Says Happens Next.
↗
October 08, 2026
Pfizer is deeply unloved, and for good reason, but don't count this drug maker out just yet.
Via
The Motley Fool
Topics
Intellectual Property
Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound
↗
October 07, 2026
The company is far from a one-trick pony.
Via
The Motley Fool
Wednesday's session: top gainers and losers in the S&P500 index
↗
October 07, 2026
Via
Chartmill
The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide.
↗
October 06, 2026
People have long been willing to pay for healthcare despite rising costs, with Medtronic and Eli Lilly offering two different angles on the space.
Via
The Motley Fool
Topics
Economy
Energy
Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?
↗
October 06, 2026
Novo Nordisk has a huge opportunity in GLP-1 weight-loss drugs, but it has to prove it can use that success to build for the future.
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
↗
October 06, 2026
Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus.
Via
The Motley Fool
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
October 06, 2026
From
Wall Street Investor
Via
GlobeNewswire
IYH Beats IXJ on Returns While Global Fund Offers Higher Yield
↗
October 06, 2026
U.S. healthcare stocks delivered 28.8% gains over one year versus 22.5% for international peers. Both funds carry nearly identical expense ratios and low volatility profiles.
Via
The Motley Fool
Topics
ETFs
2 Cash-Producing Stocks for Long-Term Investors and 1 Facing Headwinds
October 06, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
↗
October 05, 2026
The healthcare stock's elevated valuation bakes in high expectations, leaving little room for error.
Via
The Motley Fool
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
↗
October 05, 2026
Eli Lilly is partnering with Ginkgo Bioworks on drug discovery.
Via
The Motley Fool
Topics
Artificial Intelligence
If I Were in My 40s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever
↗
October 05, 2026
Owning a low-cost index fund is one of the simplest ways to build wealth in the stock market over the long term.
Via
The Motley Fool
Topics
ETFs
Economy
Retirement
Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
↗
October 05, 2026
Eli Lilly is dominating the GLP-1 market with nearly 50% revenue growth and a newly approved oral obesity pill. Pfizer is rebuilding its pipeline with obesity drug ambitions and a committed dividend...
Via
The Motley Fool
Topics
Intellectual Property
Here Are My Top 4 Stocks to Buy in October
↗
October 05, 2026
Get 'em while they're still on sale. Catalysts are on the horizon.
Via
The Motley Fool
Topics
Artificial Intelligence
Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech
↗
October 05, 2026
Fidelity offers lower costs and steadier returns, while State Street targets smaller biotech companies with higher volatility and recent outperformance.
Via
The Motley Fool
Topics
ETFs
Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBB
↗
October 05, 2026
VHT offers broad sector exposure, while IBB concentrates on biotech with higher growth but steeper drawdowns.
Via
The Motley Fool
Topics
ETFs
1 Mid-Cap Stock to Keep an Eye On and 2 We Ignore
October 05, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
